Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Adjusting Moran’s I for population density,

Go back to Resources

Adjusting Moran’s I for population density,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS,

Go back to Resources

A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A longitudinal study of the natural history of growth post-transplantation,

Go back to Resources

A longitudinal study of the natural history of growth post-transplantation,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

A comparison of methods for computing confidence intervals for vaccine efficacy in the prospective design of efficacy trials,

Go back to Resources

A comparison of methods for computing confidence intervals for vaccine efficacy in the prospective design of efficacy trials,

Authors:

Go back to Resources

The effect of deprenyl and levadopa on the progression of Parkinson’s Disease,

Go back to Resources

The effect of deprenyl and levadopa on the progression of Parkinson’s Disease,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Steady improvement in renal allograft survival among North American children. A five year appraisal by the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Steady improvement in cadaver graft survival (GS) among North American children. A 5-year appraisal by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Steady improvement in cadaver graft survival (GS) among North American children. A 5-year appraisal by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): II. Short and long-term effects of viral prophylaxis (PX),

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): II. Short and long-term effects of viral prophylaxis (PX),

Authors:

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): I. Changing patterns and risk factors,

Go back to Resources

Serious cytomegalovirus (CMV) infections following pediatric renal transplantation (RTx): I. Changing patterns and risk factors,

Authors:

Go back to Resources

Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eye,

Go back to Resources

Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eye,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Current page 101
  • Page 102
  • Page 103
  • Page 104
  • Page 105
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions